Our
Projects

Mucocort AB, a Swedish MedTech innovator is currently seeking a strategic acquirer through Experia.

 

Mucocort’s flagship product, internal project name MO45A, is a first-in-class, biodegradable, mucoadhesive patch engineered for direct application to treat Recurrent Aphthous Stomatitis (RAS).

 

RAS is a highly prevalent condition affecting up to 40% of the global population over a lifetime, yet there are currently no approved prescription therapies. MO45A offers rapid pain relief and accelerated healing through a non-steroidal, drug-free dual mechanism: hygroscopic action (absorbing wound exudate) combined with non-pharmacological antimicrobial and anti-inflammatory effects (suppressing cytokines IL-2 and TNF-α).

 

The product is classified as a Class IIa medical device and is advancing toward CE-marking. Clinical studies are ongoing under ISO 14155, manufacturing has been secured, and patents have been granted in Europe, China, Australia, and Japan, providing protection through 2040.

 

Rather than building its own commercial infrastructure, Mucocort’s shareholders are seeking a full acquisition by a partner with established marketing and distribution capabilities within MedTech, oral care, or consumer health.

 

This represents a unique opportunity to acquire:

• A clinically validated, patent-protected technology,

• Positioned in a $2.65 billion global market with significant unmet need,

• Supported by scalable manufacturing and a clear regulatory path.

 

Interested in this opportunity? An Executive Summary with additional information can be requested here: info@experia.se 

​​

Sesta Terra ("Sixth Land") is a natural resort on the Ligurian coast of Italy. It is located just north of the UNESCO world heritage site Cinque Terre ("Five Lands") . The resort is a popular luxury destination for both Italian and international visitors who require a tourist experience of immersion in nature without sacrificing comfort. A truly unique resort in beautiful Italy.

​

Sesta Terra presents a compelling opportunity for investors seeking exposure to a high-performing hospitality asset with clear pathways for scalable growth and value creation.

 

The shareholder family is interested in selling the company, including all assets, licenses and trademarks, and they have engaged Experia Corporate Finance Advisors as their financial advisor to find a new owner for the company. For more information: info@experia.se

​

Experia, representing a large buyer in Continental Europe, is leveraging on an extensive track record in the Dental field when seeking for sizeable dental lab acquisition opportunities in the Nordics, Sweden, Finland, Denmark and Norway. Lab owners are welcome to contact us for a confidential discussion about this opportunity: hakan.persson@experia.se or +46707900111

​